Werner Cautreels, PhD

President and CEO
Selecta Biosciences
Watertown, MA, US
Prior to joining Selecta Biosciences in 2010, Dr. Cautreels was Chief Executive Officer of Solvay Pharmaceuticals, the pharmaceuticals division of the Solvay Group, in Brussels, Belgium, from 2005 until Solvay Pharmaceuticals was acquired by Abbott Laboratories in February 2010. Before becoming the CEO of Solvay Pharmaceuticals, Dr. Cautreels was its Global Head of R&D from 1998. Prior to joining Solvay, he was employed by Sanofi, Sterling‑Winthrop from 1979 to 1994, and Nycomed‑Amersham from 1994 to 1998 in a variety of R&D management positions in Europe and in the United States. Dr. Cautreels is a director of Galapagos NV in Mechelen, Belgium. He held director positions at Seres Therapeutics, Inc. in Cambridge Massachusetts from January 2013 to July 2016, at Innogenetics NV in Gent, Belgium and at ArQule Inc. in Woburn, Massachusetts each from 1999 to 2006. He was the President of the Belgian‑Luxemburg Chamber of Commerce for Russia and Belarus until June 2010. Dr. Cautreels received his Ph.D. in Chemistry, specializing in Mass Spectrometry, from the University of Antwerp (Antwerp, Belgium), and his financial and business training from the Advanced Management Program at Harvard Business School.